Life Sciences Tools and Services
Company Overview of Furiex Pharmaceuticals, Inc.
Key Executives for Furiex Pharmaceuticals, Inc.
|Sailash I. Patel||No Relationships||Chief Financial Officer, Principal Accounting Officer and Vice President of Strategic Development||58|
|Paul S. Covington M.D.||No Relationships||Senior Vice President of Clinical Development & Operations||60|
Furiex Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Fredric N. Eshelman Pharm.D.||75 Relationships||Eshelman Ventures, LLC||67|
|Wendy L. Dixon Ph.D.||66 Relationships||Alkermes plc||61|
|Peter B. Corr Ph.D.||15 Relationships||Auven Therapeutics Management L.L.L.P||68|
|Stephen R. Davis J.D.||26 Relationships||ACADIA Pharmaceuticals Inc.||55|
|June S. Almenoff M.D., Ph.D., F.A.C.P.||115 Relationships||RDD Pharma, Ltd.||59|
Furiex Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee J.D.||Stephen R. Davis||26 Relationships||3 Executives|
|Compensation Committee Ph.D.||Peter B. Corr||15 Relationships||3 Executives|
|Nominating Committee Ph.D.||Wendy L. Dixon||66 Relationships||4 Executives|
|Corporate Governance Committee Ph.D.||Wendy L. Dixon||66 Relationships||4 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.